Choroidal Melanoma
Oncology·MeSH: Uveal Melanoma
Prevalence
75.0 / 100K
Incidence
23.0 / 100K/yr
1 drug in development·1 company·5 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Bel-sar | Aura Biosciences, Inc. (AURA) |
Frequently asked questions
How many drugs are in development for Choroidal Melanoma?
BioSniper tracks 1 drug in development for Choroidal Melanoma across 1 company.
How many clinical trials target Choroidal Melanoma?
There are 5 clinical trials targeting Choroidal Melanoma tracked by BioSniper.
What is the prevalence of Choroidal Melanoma?
The estimated prevalence of Choroidal Melanoma is approximately 75.0 per 100,000 population.
Deep-dive into Choroidal Melanoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis